150 related articles for article (PubMed ID: 38424285)
1. Intra- and peritumoral radiomics features based on multicenter automatic breast volume scanner for noninvasive and preoperative prediction of HER2 status in breast cancer: a model ensemble research.
Wang H; Chen W; Jiang S; Li T; Chen F; Lei J; Li R; Xi L; Guo S
Sci Rep; 2024 Feb; 14(1):5020. PubMed ID: 38424285
[TBL] [Abstract][Full Text] [Related]
2. Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study.
Zhou J; Yu X; Wu Q; Wu Y; Fu C; Wang Y; Hai M; Tan H; Wang M
Heliyon; 2024 Apr; 10(7):e28722. PubMed ID: 38623231
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
[TBL] [Abstract][Full Text] [Related]
4. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral and peritumoral radiomics for preoperatively predicting the axillary non-sentinel lymph node metastasis in breast cancer on the basis of contrast-enhanced mammography: a multicenter study.
Lin F; Li Q; Wang Z; Shi Y; Ma H; Zhang H; Zhang K; Yang P; Zhang R; Duan S; Gu Y; Mao N; Xie H
Br J Radiol; 2023 Mar; 96(1143):20220068. PubMed ID: 36542866
[TBL] [Abstract][Full Text] [Related]
6. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
[TBL] [Abstract][Full Text] [Related]
7. Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.
Braman N; Prasanna P; Whitney J; Singh S; Beig N; Etesami M; Bates DDB; Gallagher K; Bloch BN; Vulchi M; Turk P; Bera K; Abraham J; Sikov WM; Somlo G; Harris LN; Gilmore H; Plecha D; Varadan V; Madabhushi A
JAMA Netw Open; 2019 Apr; 2(4):e192561. PubMed ID: 31002322
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.
Liu Y; Li X; Zhu L; Zhao Z; Wang T; Zhang X; Cai B; Li L; Ma M; Ma X; Ming J
Contrast Media Mol Imaging; 2022; 2022():6729473. PubMed ID: 36051932
[TBL] [Abstract][Full Text] [Related]
10. MRI-based multiregional radiomics for preoperative prediction of tumor deposit and prognosis in resectable rectal cancer: a bicenter study.
Li H; Chen XL; Liu H; Liu YS; Li ZL; Pang MH; Pu H
Eur Radiol; 2023 Nov; 33(11):7561-7572. PubMed ID: 37160427
[TBL] [Abstract][Full Text] [Related]
11. Automated breast volume scanner based Radiomics for non-invasively prediction of lymphovascular invasion status in breast cancer.
Li Y; Wu X; Yan Y; Zhou P
BMC Cancer; 2023 Aug; 23(1):813. PubMed ID: 37648970
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human epidermal growth factor receptor 2 (HER2) status in breast cancer by mammographic radiomics features and clinical characteristics: a multicenter study.
Deng Y; Lu Y; Li X; Zhu Y; Zhao Y; Ruan Z; Mei N; Yin B; Liu L
Eur Radiol; 2024 Jan; ():. PubMed ID: 38276982
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral and Peritumoral Edema Radiomics Based on Fat-Suppressed T2- Weighted Imaging for Preoperative Prediction of Triple-Negative Breast Cancer.
Sun R; Hu Y; Wang X; Huang Z; Yang Y; Zhang S; Shi F; Chen L; Liu H; Wang X
Curr Med Imaging; 2024 Apr; ():. PubMed ID: 38644724
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
Sang L; Liu Z; Huang C; Xu J; Wang H
Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.
Xu H; Liu J; Chen Z; Wang C; Liu Y; Wang M; Zhou P; Luo H; Ren J
Eur Radiol; 2022 Jul; 32(7):4845-4856. PubMed ID: 35079887
[TBL] [Abstract][Full Text] [Related]
16. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI.
Niu S; Jiang W; Zhao N; Jiang T; Dong Y; Luo Y; Yu T; Jiang X
J Cancer Res Clin Oncol; 2022 Jan; 148(1):97-106. PubMed ID: 34623517
[TBL] [Abstract][Full Text] [Related]
17. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
Front Oncol; 2022; 12():905551. PubMed ID: 35814460
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
20. Mammography-based radiomics for predicting the risk of breast cancer recurrence: a multicenter study.
Mao N; Yin P; Zhang H; Zhang K; Song X; Xing D; Chu T
Br J Radiol; 2021 Nov; 94(1127):20210348. PubMed ID: 34520235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
